Inventor
FUERSTNER CHANTAL
DE30 patents
⚠️ This page may combine multiple inventors who share the name “FUERSTNER CHANTAL”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BAYER AG
13 patentsUS6451805B1Sep 17, 2002
Substituted pyrazole derivatives for the treatment of cardiocirculatory diseases
BAYER AG88 citations98
US6180656B1Jan 30, 2001
Use of condensated (hetaryl-substituted) 1-benzal-3-pyrazol derivates for treating special diseases of the cardiovascular and the central nervous systems
BAYER AG108 citations98
US6462068B1Oct 8, 2002
Heterocyclylmethyl-substituted pyrazole derivatives
BAYER AG37 citations96
US6387940B1May 14, 2002
Heterocyclylmethyl-substituted pyrazole derivatives
BAYER AG40 citations96
US6166027ADec 26, 2000
Heterocyclylmethyl-substituted pyrazole derivatives and their use for treating cardiovascular diseases
BAYER AG68 citations96
US6414009B1Jul 2, 2002
Heterocyclylmethyl-substituted pyrazol derivatives
BAYER AG29 citations93
US6410740B1Jun 25, 2002
Heterocyclylmethyl-substituted pyrazol derivatives
BAYER AG32 citations93
US6589949B1Jul 8, 2003
3-oxo-2,1-benzisoxazol-1(3H)-carboxamides for treatment of CNS diseases
BAYER AG23 citations91
US11298367B2Apr 12, 2022
Prodrugs of substituted triazole derivatives and uses thereof
BAYER AG0 citations60
US11173151B2Nov 16, 2021
Substituted triazole derivatives and uses thereof
BAYER AG0 citations51
US11149018B2Oct 19, 2021
Substituted N-arylethyl-2-aminoquinoline-4-carboxamides and use thereof
BAYER AG0 citations47
US11136296B2Oct 5, 2021
Substituted N-arylethyl-2-arylquinoline-4-carboxamides and use thereof
BAYER AG0 citations47
US6344471B1Feb 5, 2002
2-aminocarbonyl-5(2H)-isoxazolones as ligands of a DFP-binding site treatment of CNS-diseases
BAYER AG0 citations38
AICURIS GMBH & CO KG
9 patentsUS7531507B2May 12, 2009
Acylated nonadepsipeptides containing pyridyl alanine residues
AICURIS GMBH & CO KG11 citations82
US7368424B2May 6, 2008
Acylated nonadepsipeptides
AICURIS GMBH & CO KG11 citations82
US7569563B2Aug 4, 2009
Substituted quinolones II
AICURIS GMBH & CO KG4 citations62
US7737120B2Jun 15, 2010
Methods for the specific preparation of lysobactin fragments
AICURIS GMBH & CO KG0 citations52
US7977349B2Jul 12, 2011
Substituted quinolones III
AICURIS GMBH & CO KG1 citations51
US7727956B2Jun 1, 2010
Deoxonadepsipeptides
AICURIS GMBH & CO KG1 citations50
US7867992B2Jan 11, 2011
Substituted quinolones
AICURIS GMBH & CO KG0 citations41
US7786079B2Aug 31, 2010
Substituted nonadepsipeptides
AICURIS GMBH & CO KG0 citations40
US7718611B2May 18, 2010
Cyclic nonapeptide amides
AICURIS GMBH & CO KG0 citations40
Bayer Pharma AG
5 patentsUS11091463B2Aug 17, 2021
Amide-substituted pyridinyltriazole derivatives and uses thereof
Bayer Pharma AG0 citations61
US11331314B2May 17, 2022
Amine substituted triazole derivatives and uses thereof
Bayer Pharma AG0 citations51
US11230540B2Jan 25, 2022
Substituted triazole derivatives and uses thereof
Bayer Pharma AG0 citations51
US10927098B2Feb 23, 2021
Hydroxyalkyl-substituted triazole derivatives and uses thereof
Bayer Pharma AG0 citations51
US11149023B2Oct 19, 2021
Substituted triazole derivatives and uses thereof
Bayer Pharma AG0 citations50